| ₹ crore | Q2 FY27 | Q2 FY26 | Change |
|---|---|---|---|
| Revenue | 23,295 | 19,607 | +18.8% |
| EBITDA | 3,721 | 3,094 | +20.3% |
| EBITDA margin | 16.0% | 15.8% | +0.2 pts |
| Profit before tax | 2,061 | 1,662 | +24.0% |
| Net profit | 1,501 | 1,238 | +21.3% |
| EPS | ₹50.78 | ₹41.87 | +21.3% |
Amounts on the left scale in ₹ crore; per cent on the right, dashed. L = lakh crore, K = thousand crore. Touch the chart to read any period.
| Tap a line for its trend | Currentlast 12M | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 3,27,213 | — | — | — | — | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| 2,554 | 4,090 | 3,326 | 6,038 | 6,207 | ||
| 4,115 | 4,089 | 3,187 | 55.9 | 55.6 | ||
| 22,781 | 22,781 | 23,031 | 10,298 | 9,901 | ||
| 3,51,554 | — | — | — | — | ||
| 95,572 | 88,512 | 75,955 | 70,908 | 63,240 | ||
| — | +16.5% | +7.1% | +12.1% | — | ||
| 18,252 | 17,020 | 12,557 | 12,969 | 10,620 | ||
| 19.1% | 19.2% | 16.5% | 18.3% | 16.8% | ||
| 13,448 | 12,376 | 8,543 | 9,823 | 7,732 | ||
| 8,835 | 8,188 | 6,040 | 7,004 | 5,073 | ||
| 9.2% | 9.3% | 8.0% | 9.9% | 8.0% | ||
| ₹298.67 | ₹277.10 | ₹204.94 | ₹237.72 | ₹172.17 | ||
| — | +35.2% | −13.8% | +38.1% | — | ||
| — | 15,316 | 10,673 | 10,898 | 9,069 | ||
| — | −9,678 | −9,129 | −9,006 | −6,200 | ||
| 5,638 | 5,638 | 1,544 | 1,892 | 2,868 | ||
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
In ₹ Crore except Per Share 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Current/LTM TTM · last close | |
|---|---|---|---|---|---|---|
| Market Capitalization | — | — | — | — | 3,27,212.7 | |
| - Cash, Equiv & ST Investments | 6,207.0 | 6,038.4 | 3,326.3 | 4,090.1 | 2,554.1 | |
| + Minority Interest | 55.6 | 55.9 | 3,186.6 | 4,088.9 | 4,114.8 | |
| + Total Debt | 9,900.8 | 10,298.4 | 23,031.0 | 22,780.7 | 22,780.7 | |
| Enterprise Value | — | — | — | — | 3,51,554.0 | |
| Revenue | 63,240.0 | 70,908.1 | 75,955.1 | 88,511.5 | 95,572.4 | |
| Growth %, YoY | — | +12.1 | +7.1 | +16.5 | — | |
| EBITDA | 10,619.9 | 12,968.6 | 12,557.5 | 17,020.2 | 18,252.3 | |
| Margin % | 16.79 | 18.29 | 16.53 | 19.23 | 19.10 | |
| EBIT | 7,731.9 | 9,823.3 | 8,542.5 | 12,375.8 | 13,448.4 | |
| Net Income | 5,073.4 | 7,004.0 | 6,039.6 | 8,188.4 | 8,834.6 | |
| Margin % | 8.02 | 9.88 | 7.95 | 9.25 | 9.24 | |
| EPS, Adj (current shares) | 172.17 | 237.72 | 204.94 | 277.10 | 298.67 | |
| Growth %, YoY | — | +38.1 | -13.8 | +35.2 | — | |
| Cash from Operations | 9,068.5 | 10,897.5 | 10,673.4 | 15,315.9 | — | |
| Capital Expenditures | -6,200.1 | -9,005.6 | -9,129.3 | -9,677.8 | — | |
| Free Cash Flow | 2,868.4 | 1,892.0 | 1,544.1 | 5,638.1 | 5,638.1 | |
Prices at the 29 October 2026 close · figures from the company's filings with NSE
UltraTech Cement (NSE: ULTRACEMCO) had a market capitalisation of ₹3,29,305 crore at the 29 October 2026 close (₹11,175.00 a share), a PE ratio of 37.4 on the last four quarters' profit and a price-to-book ratio of 4.48. In FY26 its consolidated net profit attributable to shareholders was ₹8,166 crore on revenue of ₹88,512 crore; in Q2 FY27 (July–September 2026) it was ₹1,494 crore, up 21.3% year on year. Its debt-to-equity ratio was 0.37 on 30 September 2026. Promoters held 58.48% of the shares on 30 September 2026.
UltraTech Cement's PE ratio is 37.4 at the 29 October 2026 close (₹11,175.00 a share): a market capitalisation of ₹3,29,305 crore divided by consolidated net profit attributable to shareholders of ₹8,801 crore over the last four quarters (Q3 FY26 to Q2 FY27). On FY26 net profit attributable to shareholders (₹8,166 crore) it is 40.3.
UltraTech Cement's price-to-book (PB) ratio is 4.48 at the 29 October 2026 close: a market capitalisation of ₹3,29,305 crore divided by shareholders' equity (book value) of ₹73,587 crore on 30 September 2026. That is a book value of ₹2,497.19 per share against a share price of ₹11,175.00.
In FY26, UltraTech Cement's return on equity (ROE) was 11.1% and its return on capital employed (ROCE) was 11.9%. ROE is net profit attributable to shareholders divided by average shareholders' equity (the start and end of the year); ROCE is operating profit (EBIT) divided by average capital employed (total assets less current liabilities). In FY25, ROE was 9.2% and ROCE 9.8%.
UltraTech Cement's market capitalisation was ₹3,29,305 crore (₹3.29 lakh crore) at the 29 October 2026 close: 29.47 crore shares at ₹11,175.00 each.
UltraTech Cement's basic earnings per share (EPS) were ₹277.62 in FY26, against ₹205.30 in FY25. Over the last four quarters (Q3 FY26 to Q2 FY27) they add up to ₹299.21.
In 2026, UltraTech Cement has declared one dividend: ₹240 with record date 30 July 2026.
No. UltraTech Cement had borrowings of ₹28,411 crore on 30 September 2026 (consolidated balance sheet), a debt-to-equity ratio of 0.37. Its cash and current investments were ₹4,126 crore, so its net debt was ₹24,285 crore.
UltraTech Cement's debt-to-equity ratio was 0.37 on 30 September 2026: borrowings of ₹28,411 crore against total equity of ₹77,702 crore. A year earlier, on 30 September 2025, it was 0.32.
UltraTech Cement's dividend yield is 2.15% at the 29 October 2026 close: dividends of ₹240 a share that went ex-dividend in the 12 months before that day, divided by the share price of ₹11,175.00. They were ₹240 on 30 July 2026.
UltraTech Cement's net worth — shareholders' equity in its consolidated balance sheet — was ₹73,587 crore on 30 September 2026, up 2.2% from ₹72,033 crore a year earlier. Its market value is a different figure: a market capitalisation of ₹3,29,305 crore at the 29 October 2026 close.
UltraTech Cement's book value per share was ₹2,497.19 on 30 September 2026: shareholders' equity of ₹73,587 crore divided by the 29.47 crore shares in issue, up 2.2% from ₹2,444.43 a year earlier. The share price at the 29 October 2026 close was ₹11,175.00.
UltraTech Cement's latest results are for Q2 FY27 (July–September 2026), filed on 19 October 2026: consolidated net profit attributable to shareholders ₹1,494 crore, up 21.3% from ₹1,232 crore in Q2 FY26; revenue from operations ₹23,295 crore, up 18.8% year on year.
Promoters held 58.48% of UltraTech Cement on 30 September 2026, down 0.85 percentage points from 59.33% the previous quarter and down 0.75 percentage points from 59.23% a year earlier, according to the shareholding pattern filed with NSE.
In FY26, UltraTech Cement generated ₹15,316 crore of cash from operations and spent ₹9,678 crore on capital expenditure (property, plant, equipment and intangibles), leaving free cash flow of ₹5,638 crore. In FY25 it was ₹1,544 crore.
UltraTech Cement has reported Q2 FY27. Its next results, for Q3 FY27 (October–December 2026), are due by 14 February 2027 under SEBI's 45-day rule; the company notifies the board-meeting date at least two working days before.
On 30 September 2026, UltraTech Cement's shares were held by promoters 58.48%, foreign portfolio investors (FII/FPI) 12.69%, domestic institutions (DII) 20.86% (including mutual funds at 16.40%) and retail and other non-institutional investors 7.71%. Over the year, FII holding was down 3.13 percentage points from 15.82% and DII holding was up 4.21 percentage points from 16.65%.
In FY26 (April 2025–March 2026), UltraTech Cement's consolidated net profit attributable to shareholders was ₹8,166 crore, up 35.2% from ₹6,039 crore in FY25, on revenue from operations of ₹88,512 crore (up 16.5%). Over three years, from FY23, net profit was up 61.0%.
At the 29 October 2026 closing prices, on FY26 net profit attributable to shareholders, UltraTech Cement's PE ratio is 40.3, the second highest of the four: Ambuja Cements 18.6, Shree Cement 47.8 and ACC 10.1, a peer average of 25.5. Each is the company's market capitalisation at that price divided by its FY26 net profit.
On FY26 consolidated figures, against Ambuja Cements, Shree Cement and ACC: UltraTech Cement's operating margin of 14.0% is the highest of the four (Ambuja Cements 7.3%, Shree Cement 8.8%, ACC 7.1%; peer average 7.7%); its return on equity of 11.1% is the highest of the four (Ambuja Cements 8.4%, Shree Cement 7.8%, ACC 10.9%; peer average 9.0%); its revenue growth over three years of 11.9% a year is the highest of the four (Ambuja Cements 1.5% a year, Shree Cement 5.5% a year, ACC 5.3% a year; peer average 4.1% a year).
In FY26, UltraTech Cement earned net profit attributable to shareholders of ₹8,166 crore on revenue of ₹88,512 crore, against ₹4,728 crore on ₹40,656 crore for Ambuja Cements. UltraTech Cement's operating margin was 14.0% (Ambuja Cements 7.3%) and its return on equity 11.1% (Ambuja Cements 8.4%). At the 29 October 2026 close, UltraTech Cement's market capitalisation was ₹3,29,305 crore against ₹88,143 crore for Ambuja Cements, and its PE ratio on FY26 profit 40.3 against 18.6.
From UltraTech Cement's own consolidated results, balance sheets and shareholding patterns filed with NSE, and NSE prices (the latest used here: the 29 October 2026 close). Ratios are calculated by Alphave from those filings as each answer describes.
Consolidated figures from the company's filings with NSE; prices are NSE closing prices.